Literature DB >> 24962140

M-CSF priming of osteoclast precursors can cause osteoclastogenesis-insensitivity, which can be prevented and overcome on bone.

Teun J De Vries1, Ton Schoenmaker, David Aerts, Lilyanne C Grevers, Pedro P C Souza, Kamran Nazmi, Mark van de Wiel, Bauke Ylstra, Peter L Van Lent, Pieter J M Leenen, Vincent Everts.   

Abstract

Osteoclasts and macrophages share progenitors that must receive decisive lineage signals driving them into their respective differentiation routes. Macrophage colony stimulation factor M-CSF is a common factor; bone is likely the stimulus for osteoclast differentiation. To elucidate the effect of both, shared mouse bone marrow precursor myeloid blast was pre-cultured with M-CSF on plastic and on bone. M-CSF priming prior to stimulation with M-CSF and osteoclast differentiation factor RANKL resulted in a complete loss of osteoclastogenic potential without bone. Such M-CSF primed cells expressed the receptor RANK, but lacked the crucial osteoclastogenic transcription factor NFATc1. This coincided with a steeply decreased expression of osteoclast genes TRACP and DC-STAMP, but an increased expression of the macrophage markers F4/80 and CD11b. Compellingly, M-CSF priming on bone accelerated the osteoclastogenic potential: M-CSF primed cells that had received only one day M-CSF and RANKL and were grown on bone already expressed an array of genes that are associated with osteoclast differentiation and these cells differentiated into osteoclasts within 2 days. Osteoclastogenesis-insensitive precursors grown in the absence of bone regained their osteoclastogenic potential when transferred to bone. This implies that adhesion to bone dictates the fate of osteoclast precursors. Common macrophage-osteoclast precursors may become insensitive to differentiate into osteoclasts and regain osteoclastogenesis when bound to bone or when in the vicinity of bone.
© 2014 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 24962140     DOI: 10.1002/jcp.24702

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  15 in total

1.  Macrophage colony-stimulating factor pretreatment of bone marrow progenitor cells regulates osteoclast differentiation based upon the stage of myeloid development.

Authors:  Xuehui Yang; Shivangi Pande; Cameron Scott; Robert Friesel
Journal:  J Cell Biochem       Date:  2019-02-25       Impact factor: 4.429

2.  NHA2 promotes cyst development in an in vitro model of polycystic kidney disease.

Authors:  Hari Prasad; Donna K Dang; Kalyan C Kondapalli; Niranjana Natarajan; Valeriu Cebotaru; Rajini Rao
Journal:  J Physiol       Date:  2018-10-17       Impact factor: 5.182

3.  Nobiletin-loaded micelles reduce ovariectomy-induced bone loss by suppressing osteoclastogenesis.

Authors:  Yabing Wang; Jian Xie; Zexin Ai; Jiansheng Su
Journal:  Int J Nanomedicine       Date:  2019-09-26

4.  HMGB1 promotes the secretion of multiple cytokines and potentiates the osteogenic differentiation of mesenchymal stem cells through the Ras/MAPK signaling pathway.

Authors:  Lin Feng; Deting Xue; Erman Chen; Wei Zhang; Xiang Gao; Jiawei Yu; Yadong Feng; Zhijun Pan
Journal:  Exp Ther Med       Date:  2016-11-02       Impact factor: 2.447

5.  TNF‑α and RANKL promote osteoclastogenesis by upregulating RANK via the NF‑κB pathway.

Authors:  Gang Luo; Fangfei Li; Xiaoming Li; Zheng-Guo Wang; Bo Zhang
Journal:  Mol Med Rep       Date:  2018-03-07       Impact factor: 2.952

6.  TNF-α has both stimulatory and inhibitory effects on mouse monocyte-derived osteoclastogenesis.

Authors:  Yixuan Cao; Ineke D C Jansen; Sara Sprangers; Teun J de Vries; Vincent Everts
Journal:  J Cell Physiol       Date:  2017-07-17       Impact factor: 6.384

Review 7.  Immune Function and Diversity of Osteoclasts in Normal and Pathological Conditions.

Authors:  Maria-Bernadette Madel; Lidia Ibáñez; Abdelilah Wakkach; Teun J de Vries; Anna Teti; Florence Apparailly; Claudine Blin-Wakkach
Journal:  Front Immunol       Date:  2019-06-19       Impact factor: 7.561

Review 8.  The role of "bone immunological niche" for a new pathogenetic paradigm of osteoporosis.

Authors:  Danilo Pagliari; Francesco Ciro Tamburrelli; Gianfranco Zirio; Estelle E Newton; Rossella Cianci
Journal:  Anal Cell Pathol (Amst)       Date:  2015-09-30       Impact factor: 2.916

9.  A Potent Tartrate Resistant Acid Phosphatase Inhibitor to Study the Function of TRAP in Alveolar Macrophages.

Authors:  Carian E Boorsma; T Anienke van der Veen; Kurnia S S Putri; Andreia de Almeida; Christina Draijer; Thais Mauad; Gyorgy Fejer; Corry-Anke Brandsma; Maarten van den Berge; Yohan Bossé; Don Sin; Ke Hao; Anja Reithmeier; Göran Andersson; Peter Olinga; Wim Timens; Angela Casini; Barbro N Melgert
Journal:  Sci Rep       Date:  2017-10-03       Impact factor: 4.379

10.  Hypoxia negatively affects senescence in osteoclasts and delays osteoclastogenesis.

Authors:  Ben Gorissen; Alain de Bruin; Alberto Miranda-Bedate; Nicoline Korthagen; Claudia Wolschrijn; Teun J de Vries; René van Weeren; Marianna A Tryfonidou
Journal:  J Cell Physiol       Date:  2018-06-22       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.